SI-BONE, INC. (SIBN) Gross Margin
- Gross margin · 12 months: Value 79.53%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 79.53% | Gross profit / revenue. Period ending 2026-06-30. $169.87M ÷ $213.60M × 100 ≈ 79.53% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 169.87M USD | Gross Profit |
| Revenue | 213.60M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 43.73M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $169.87M | $213.60M | $43.73M | 79.53% |
| 2026-03-31 | $164.13M | $206.22M | $42.09M | 79.59% |
| 2025-12-31 | $159.88M | $200.93M | $41.05M | 79.57% |
| 2025-09-30 | $154.13M | $193.58M | $39.45M | 79.62% |
| 2025-06-30 | $147.18M | $185.26M | $38.08M | 79.45% |
| 2025-03-31 | $139.95M | $176.60M | $36.65M | 79.25% |
| 2024-12-31 | $132.12M | $167.18M | $35.06M | 79.03% |
| 2024-09-30 | $122.02M | $157.03M | $35.02M | 77.70% |
| 2024-06-30 | $117.09M | $150.71M | $33.62M | 77.69% |
| 2024-03-31 | $112.50M | $144.04M | $31.54M | 78.10% |
| 2023-12-31 | $109.42M | $138.89M | $29.47M | 78.78% |
| 2023-09-30 | $107.61M | $131.98M | $24.37M | 81.53% |
| 2023-06-30 | $102.90M | $124.40M | $21.50M | 82.72% |
| 2023-03-31 | $98.03M | $116.68M | $18.65M | 84.02% |
| 2022-12-31 | $90.70M | $106.41M | $15.71M | 85.24% |
| 2022-09-30 | $85.69M | $99.69M | $13.99M | 85.96% |
| 2022-06-30 | $83.24M | $95.54M | $12.30M | 87.12% |
| 2022-03-31 | $80.94M | $92.15M | $11.21M | 87.83% |
| 2021-12-31 | $79.72M | $90.15M | $10.43M | 88.43% |
| 2021-09-30 | $77.74M | $87.07M | $9.33M | 89.29% |
| 2021-06-30 | $75.72M | $85.15M | $9.43M | 88.93% |
| 2021-03-31 | $67.84M | $77.01M | $9.17M | 88.09% |
| 2020-12-31 | $64.48M | $73.39M | $8.90M | 87.87% |
| 2020-09-30 | $62.38M | $71.05M | $8.67M | 87.79% |
| 2020-06-30 | $59.14M | $66.86M | $7.72M | 88.45% |
| 2020-03-31 | $61.94M | $69.13M | $7.20M | 89.59% |
| 2019-12-31 | $60.51M | $67.30M | $6.79M | 89.91% |
| 2019-09-30 | $56.99M | $63.11M | $6.13M | 90.29% |
| 2019-06-30 | $54.60M | $60.31M | $5.72M | 90.52% |
| 2019-03-31 | $52.35M | $57.66M | $5.31M | 90.79% |
| 2018-12-31 | $50.55M | $55.38M | $4.83M | 91.27% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | $42.87M | $47.98M | $5.11M | 89.35% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |